Skip to main content
Clinical Trials/NCT03515642
NCT03515642
Withdrawn
Not Applicable

Effect of Two Exercise Programme on Gut Microbiota, Hepatic Metabolism and Adipokines in Sedentary Adults With Overweight

Universidad Santo Tomas1 site in 1 countryMarch 25, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Metabolic Disturbance
Sponsor
Universidad Santo Tomas
Locations
1
Primary Endpoint
Gut microbiota
Status
Withdrawn
Last Updated
6 years ago

Overview

Brief Summary

This project offers the opportunity to obtain detailed measurements on the health of body composition, metabolic health, and intestinal microbial diversity in overweight adults; moreover to provide information about the effects of physical exercise on them. The aim of the research is to advance in the understanding of the mechanisms induced by physical exercise, which includes the measurement of nutritional parameters, clinical and biochemical biomarkers of hepatic/cardiometabolic health, as well as the application of differential proteomics technologies by means of Arrays of cytokines and intestinal microbiome, making this study a novel and pioneer in sensitive areas of primary health care in Latin America.

Registry
clinicaltrials.gov
Start Date
March 25, 2018
End Date
August 30, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Sedentary males
  • BMI\>25 kg/m2, on a stable body weight for the last 3 months

Exclusion Criteria

  • Acute or chronic illness
  • Use of antibiotics the past 2 months

Outcomes

Primary Outcomes

Gut microbiota

Time Frame: Baseline, and 6 weeks immediately after the interventions ends

Change from Baseline in the gut microbiota composition measured by amplicon sequencing

Plasma metabolomic profile

Time Frame: Baseline, and 6 weeks immediately after the interventions ends

Change from Baseline in the metabolomic profile will be also evaluated by a HPLC-MS approach

Secondary Outcomes

  • Plasma hepatokines(Baseline, and 6 weeks immediately after the interventions ends)
  • Body composition(Baseline, and 6 weeks immediately after the interventions ends)
  • Glucose(Baseline, and 6 weeks immediately after the interventions ends)
  • Insulin(Baseline, and 6 weeks immediately after the interventions ends)
  • Physical fitness(Baseline, and 6 weeks immediately after the interventions ends)
  • Glycated hemoglobin(Baseline, and 6 weeks immediately after the interventions ends)
  • Bioinflammatory blood markers(Baseline, and 6 weeks immediately after the interventions ends)
  • Energy substrate oxidation(Baseline, and 6 weeks immediately after the interventions ends)
  • Resting Metabolic Rate(Baseline, and 6 weeks immediately after the interventions ends)

Study Sites (1)

Loading locations...

Similar Trials